Speakers
Constrained Peptides and Macrocyclics Drug Discovery
Steven Ballet, Ph.D., Research Group of Organic Chemistry, Departments of Bio-Engineering Sciences and Chemistry, Vrije Universiteit Brussel
Christophe Bonny, Ph.D., CSO, Bicycle Therapeutics Limited
Julio Camarero, Ph.D., Associate Professor, Pharmacology and Chemistry, University of Southern California
Jennifer Cochran, Ph.D., Associate Professor, Bioengineering, Stanford University
Sarah #$%$, Ph.D., Senior Scientist II, Chemistry Department, Affymax, Inc.
Ian Lewis, Ph.D., Research Chemist, Global Discovery Chemistry, Novartis
Daniel Obrecht, Ph.D., CSO, Polyphor, Ltd.
Dinesh Patel, Ph.D., CEO, Protagonist Therapeutics
Tomi Sawyer, Ph.D., CSO, Aileron Therapeutics
Jack W. Szostak, Ph.D., Investigator, Howard Hughes Medical Institute; Professor of Genetics, Harvard Medical School; Nobel Laureate
Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.
Helmut Thomas, Ph.D., Senior Vice President, Research and Pre-Clinical Development, Tranzyme Pharma
Douglas A. Treco, Ph.D., President and CEO, Ra Pharmaceuticals
Christoph Zapf, Ph.D., Principal Scientist, Worldwide Medicinal Chemistry, Pfizer
